El fracaso a anticuerpos monoclonales frente a CGRP o su receptor no implica la inefectividad a otros fármacos de la misma clase terapéutica / Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class
Neurología (Barc., Ed. impr.)
; 36(8): 638-640, octubre 2021. tab
Article
in Spanish
| IBECS
| ID: ibc-220118
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Pharmaceutical Preparations
/
Calcitonin Gene-Related Peptide
/
Antibodies, Monoclonal
Limits:
Humans
Language:
Spanish
Journal:
Neurología (Barc., Ed. impr.)
Year:
2021
Document type:
Article
Institution/Affiliation country:
Hospital Clínico San Carlos/España
/
Hospital Clínico Universitario San Carlos/España
/
Hospital Clínico Universitario de Valladolid/España